Tackling Modern-Day Pharma Challenges with eLearning
Enyota Learning
MAY 25, 2018
From marking the end of the Hepatitis-C treatment era, which was a significant contributor to the industry’s growth rate from 2014– 2016, to the greater impact of expiring patents and the introduction of Biosimilars, the year has been quite phenomenal.
Let's personalize your content